General
Showing 2017–2032 of 2282 results
-
Article: Real-life outcome of optimally treated patients with malignant glioma
€3.03 Add to cart -
Article: Real-world evidence in the treatment of high-risk acute myeloid leukemia
€3.03 Add to cart -
Article: Rebuttal to ‘The COMPARZ study presented at ESMO 2012: how pliable is non-inferiority?’
€3.03 Add to cart -
Article: Rebuttal to “The role of direct oral anticoagulants in the management of cancer-associated thrombosis’
€3.03 Add to cart -
Article: Recent advances in haemophilia treatment
€3.03 Add to cart -
Article: Recent advances in haemophilia treatment
€3.03 Add to cart -
Article: Recent advances in haemophilia treatment
€3.03 Add to cart -
Article: Recent advances in targeted therapies for patients with acute myeloid leukemia
€3.03 Add to cart -
Article: Recent advances in the genomic and epigenomic biology of juvenile myelomonocytic leukaemia
€3.03 Add to cart -
Article: Recent advances in the treatment of acute leukemia
€3.03 Add to cart -
Article: Recurrent and metastatic non-nasopharyngeal head and neck cancer: state of the art of systemic treatment
€3.03 Add to cart -
Article: Recurrent deep venous thrombo-embolism in an obese anticoagulated patient
€3.03 Add to cart -
Article: Refractory immune thrombocytopenic purpura in a child with vitamin D deficiency
€3.03 Add to cart -
Article: Regulatory T cells: from bench to bedside
€3.03 Add to cart -
Article: RELEVANCE: A phase 3 randomised study comparing efficacy and safety of rituximab plus lenalidomide versus rituximab plus chemotherapy in first-line patients with follicular lymphomat
€3.03 Add to cart -
Article: RELEVANCE: A phase 3 randomised study comparing efficacy and safety of rituximab plus lenalidomide versus rituximab plus chemotherapy in first-line patients with follicular lymphomat
€3.03 Add to cart
